• Profile
Close

Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype

Alimentary Pharmacology and Therapeutics Sep 20, 2017

Broekman MMTJ, et al. - An analysis was performed to identify the clinical risk factors for thiopurine-induced leucopenia in patients without a common thiopurine S-methyltransferase (TPMT) variant, and investigate if these patients were at increased risk for infections. In patients without a TPMT variant, low baseline white blood cell (WBC) count and mercaptopurine were risk factors for thiopurine-induced leucopenia because of a relatively higher dose.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay